Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5489157 | 0.98 | ALDH1A1 (0.33) | ALDH1A1CYP1A1CYP1A2CYP3A4HPGD | |
| SCHEMBL29012925 | 0.97 | ALDH1A1 (0.32) | ALDH1A1CYP1A1CYP1A2CYP3A4HPGD | |
| Hydroxyamine SCHEMBL29210814 | 0.95 | ALDH1A1 (0.31) | ALDH1A1CYP1A1CYP1A2CYP3A4HPGD | |
| SCHEMBL900144 | 0.94 | ALDH1A1 (0.30) | ALDH1A1CYP1A1CYP1A2CYP3A4HPGD | |
| Acetonitrile SCHEMBL29013766 | 0.90 | — | — | |
| Alcohol SCHEMBL29044093 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL28198085 | 0.84 | CYP3A4 (0.33) | ALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL10870531 | 0.80 | ALDH1A1 (0.32) | ALDH1A1CYP1A1CYP1A2CYP3A4HPGD | |
| SCHEMBL28097865 | 0.78 | DHFR (0.36) | ALDH1A1HSD17B10 | |
| SCHEMBL5534355 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0752102-B1 | IMMUNOENZYMATIC CONJUGATE, PREPARATION METHOD THEREFOR AND USES THEREOF | PASTEUR SANOFI DIAGNOSTICS (FR) | 2000-11-15 | — | — | EP | claimed |